Details for New Drug Application (NDA): 211484
✉ Email this page to a colleague
NDA 211484 describes LEVORPHANOL TARTRATE, which is a drug marketed by Hikma, Novitium Pharma, Specgx Llc, Sun Pharm Inds Inc, and Virtus, and is included in five NDAs. It is available from six suppliers. Additional details are available on the LEVORPHANOL TARTRATE profile page.
The generic ingredient in LEVORPHANOL TARTRATE is levorphanol tartrate. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the levorphanol tartrate profile page.
The generic ingredient in LEVORPHANOL TARTRATE is levorphanol tartrate. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the levorphanol tartrate profile page.
Summary for 211484
| Tradename: | LEVORPHANOL TARTRATE |
| Applicant: | Virtus |
| Ingredient: | levorphanol tartrate |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Pharmacology for NDA: 211484
| Mechanism of Action | Full Opioid Agonists |
Medical Subject Heading (MeSH) Categories for 211484
Suppliers and Packaging for NDA: 211484
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LEVORPHANOL TARTRATE | levorphanol tartrate | TABLET;ORAL | 211484 | ANDA | Virtus Pharmaceuticals, LLC | 69543-417 | 69543-417-10 | 100 TABLET in 1 BOTTLE (69543-417-10) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
| Approval Date: | Dec 13, 2018 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
